Vote Scores

Home / Companies / AbCellera Biologics Inc. / 13 Jun 2024

Meeting · year to 30 June 2024151 filers reporting

AbCellera Biologics Inc.: meeting of 13 Jun 2024

Votes reported on Form N-PX, item by item

151 Form N-PX filers reported votes at the AbCellera Biologics Inc. meeting of 13 Jun 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 72.6% of reported votes for; 14 filers withheld from or voted against at least one nominee.

66 vote records from 28 filers. 0 of the 26 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

42.9% for0.0% against57.1% other0.0% against management28 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

168 vote records from 148 filers. 8 of the 136 filers that marked the item either way voted against management. 12 filers reported this item without a management mark.

85.8% for5.4% against8.8% other5.9% against management148 filers86.2% for13.8% against13.8% against management91,325,525 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

33 vote records from 28 filers. 0 of the 26 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

92.9% for0.0% against7.1% other0.0% against management28 filers100.0% for0.0% against0.0% against management13,734,083 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

4 vote records from 3 filers. 1 of the 3 filers that marked the item either way voted against management.

66.7% for33.3% against33.3% against management3 filers100.0% for0.0% against0.0% against management9,670,151 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalNo reportForNo report
State Street and SPDRSplit or no voteForFor
American CenturySplit or no voteForFor
InvescoSplit or no voteForFor
ProShares and ProFundsSplit or no voteForFor
Morgan Stanley, Eaton Vance and CalvertSplit or no voteForSplit or no vote
Goldman SachsNo reportForNo report
Northern Trust and FlexSharesNo reportForNo report
SEINo reportForNo report
VoyaNo reportForNo report
Brighthouse FundsForForFor
Columbia ThreadneedleSplit or no voteForFor
Capital Group and American FundsForAgainst *For
Federated HermesSplit or no voteForFor
VirtusForForFor
Natixis and Loomis SaylesNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the AbCellera Biologics Inc. meeting?

151 Form N-PX filers reported votes at the meeting of 13 Jun 2024. On say-on-pay, 8 of 136 voted against management (5.9%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by AbCellera Biologics Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for AbCellera Biologics Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing AbCellera Biologics Inc. with a meeting date within three days of 13 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.